Tetsunari Hase

2.4k total citations
93 papers, 1.2k citations indexed

About

Tetsunari Hase is a scholar working on Oncology, Biomedical Engineering and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tetsunari Hase has authored 93 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 26 papers in Biomedical Engineering and 24 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tetsunari Hase's work include Physics of Superconductivity and Magnetism (20 papers), Superconducting Materials and Applications (20 papers) and Lung Cancer Treatments and Mutations (15 papers). Tetsunari Hase is often cited by papers focused on Physics of Superconductivity and Magnetism (20 papers), Superconducting Materials and Applications (20 papers) and Lung Cancer Treatments and Mutations (15 papers). Tetsunari Hase collaborates with scholars based in Japan, United States and France. Tetsunari Hase's co-authors include Yoshinori Hasegawa, Mitsuo Sato, Masashi Kondo, Yoshitaka Sekido, Naozumi Hashimoto, Seiji Hayashi, John D. Minna, Kenya Yoshida, Y. Kawate and Kiyoshi Takahashi and has published in prestigious journals such as Journal of Clinical Oncology, Physical review. B, Condensed matter and Applied Physics Letters.

In The Last Decade

Tetsunari Hase

83 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tetsunari Hase Japan 20 348 322 276 229 224 93 1.2k
A. Brauers Germany 21 409 1.2× 127 0.4× 84 0.3× 85 0.4× 210 0.9× 62 1.5k
J Chu United States 22 286 0.8× 91 0.3× 150 0.5× 40 0.2× 421 1.9× 75 1.5k
Ioannis Stasinopoulos United States 21 266 0.8× 142 0.4× 302 1.1× 145 0.6× 74 0.3× 44 1.5k
Masashi Yamamoto Japan 20 543 1.6× 82 0.3× 116 0.4× 286 1.2× 107 0.5× 71 1.3k
Christopher Bradley United Kingdom 11 164 0.5× 54 0.2× 186 0.7× 120 0.5× 42 0.2× 39 959
Zhe Zheng China 17 573 1.6× 46 0.1× 23 0.1× 113 0.5× 188 0.8× 73 1.2k
Satoru Ishida Japan 15 511 1.5× 45 0.1× 44 0.2× 90 0.4× 48 0.2× 38 1.4k
Dali Zhang China 17 501 1.4× 137 0.4× 17 0.1× 113 0.5× 61 0.3× 65 1.3k
Masao Yano Japan 16 269 0.8× 45 0.1× 60 0.2× 54 0.2× 24 0.1× 59 1.2k
Gordon T. Kennedy United States 20 198 0.6× 454 1.4× 168 0.6× 16 0.1× 42 0.2× 59 1.2k

Countries citing papers authored by Tetsunari Hase

Since Specialization
Citations

This map shows the geographic impact of Tetsunari Hase's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsunari Hase with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsunari Hase more than expected).

Fields of papers citing papers by Tetsunari Hase

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tetsunari Hase. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsunari Hase. The network helps show where Tetsunari Hase may publish in the future.

Co-authorship network of co-authors of Tetsunari Hase

This figure shows the co-authorship network connecting the top 25 collaborators of Tetsunari Hase. A scholar is included among the top collaborators of Tetsunari Hase based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tetsunari Hase. Tetsunari Hase is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nishinakamura, Hitomi, Takuma Irie, Takeo Naito, et al.. (2025). Coactivation of innate immune suppressive cells induces acquired resistance against combined TLR agonism and PD-1 blockade. Science Translational Medicine. 17(785). eadk3160–eadk3160. 8 indexed citations
2.
Tai, Mei-Chee, Leonidas E. Bantis, Ichidai Tanaka, et al.. (2024). Circulating microRNA Panel for Prediction of Recurrence and Survival in Early-Stage Lung Adenocarcinoma. International Journal of Molecular Sciences. 25(4). 2331–2331.
3.
Hase, Tetsunari, et al.. (2024). 508 Implementation of a Palliative Care Curriculum for Emergency Medicine Residents. Annals of Emergency Medicine. 84(4). S224–S224.
4.
Fujiwara, Yutaka, Tetsunari Hase, Naozumi Hashimoto, et al.. (2023). Pharmacokinetic and dose‐finding study of osimertinib in patients with impaired renal function and low body weight. Cancer Science. 114(5). 2087–2097. 7 indexed citations
5.
Tanaka, Hiromasa, Yuki Shibata, Tetsunari Hase, et al.. (2023). High-performance glass filters for capturing and culturing circulating tumor cells and cancer-associated fibroblasts. Scientific Reports. 13(1). 4130–4130. 4 indexed citations
6.
Miyai, Yuki, Daisuke Sugiyama, Tetsunari Hase, et al.. (2022). Meflin-positive cancer-associated fibroblasts enhance tumor response to immune checkpoint blockade. Life Science Alliance. 5(6). e202101230–e202101230. 34 indexed citations
7.
Yamamoto, Takafumi, Takanori Ito, Masatoshi Ishigami, et al.. (2022). Clustering using unsupervised machine learning to stratify the risk of immune‐related liver injury. Journal of Gastroenterology and Hepatology. 38(2). 251–258. 8 indexed citations
8.
Yamamoto, Takafumi, Takanori Ito, Tetsunari Hase, et al.. (2021). Immune-related Liver Injury is a Poor Prognostic Factor in Patients with Nonsmall Cell Lung Cancer Treated with Immune Checkpoint Inhibitors. Cancer Investigation. 40(2). 189–198. 10 indexed citations
9.
Takeuchi, Shinji, Tetsunari Hase, Shinobu Shimizu, et al.. (2019). Phase I study of vorinostat with gefitinib in BIM deletion polymorphism/epidermal growth factor receptor mutation double‐positive lung cancer. Cancer Science. 111(2). 561–570. 28 indexed citations
10.
Urakawa, Hiroshi, Yukio Ando, Tetsunari Hase, et al.. (2019). Clinical value of serum bone resorption markers for predicting clinical outcomes after use of bone modifying agents in metastatic bone tumors: A prospective cohort study. International Journal of Cancer. 146(12). 3504–3515. 4 indexed citations
11.
Imaizumi, Kazuyoshi, Tetsunari Hase, Masahiro Morise, et al.. (2018). Safety and efficacy of diagnostic flexible bronchoscopy in very old patients with lung cancer. European Geriatric Medicine. 9(2). 255–262. 3 indexed citations
12.
Tanaka, Ichidai, Mitsuo Sato, Tetsunari Hase, et al.. (2018). P1.03-13 eIF2β, A Subunit of Translation-Initiation Factor EIF2, as a Potential Therapeutic Target for Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 13(10). S516–S517. 1 indexed citations
13.
Tanaka, Ichidai, Kenji Kawada, Masahiro Morise, et al.. (2017). A phase II trial of Ifosfamide combination with recommended supportive therapy for recurrent SCLC in second-line and heavily treated setting. Cancer Chemotherapy and Pharmacology. 81(2). 339–345. 4 indexed citations
14.
Morise, Masahiro, Hiroyuki Taniguchi, Hideo Saka, et al.. (2014). Phase II study of erlotinib for previously treated patients with EGFR wild-type non-small-cell lung cancer, following EGFR mutation status reevaluation with the Scorpion Amplified Refractory Mutation System. Molecular and Clinical Oncology. 2(6). 991–996. 7 indexed citations
15.
Yoshida, Kenya, Mitsuo Sato, Tetsunari Hase, et al.. (2012). TIMELESS is overexpressed in lung cancer and its expression correlates with poor patient survival. Cancer Science. 104(2). 171–177. 51 indexed citations
16.
Hase, Tetsunari, Mitsuo Sato, Kenya Yoshida, et al.. (2011). Pivotal role of epithelial cell adhesion molecule in the survival of lung cancer cells. Cancer Science. 102(8). 1493–1500. 26 indexed citations
17.
Choi, Seyong, Kiyoshi Takahashi, Shinji Matsumoto, et al.. (2009). The Electrical and Mechanical Characterization of Metal-Reinforced Bi-2223/Ag Conductors for High Field Insert Coil. IEEE Transactions on Applied Superconductivity. 19(3). 2889–2892. 4 indexed citations
18.
Hase, Tetsunari, Takehiro Noguchi, Koichi Takemura, & Yoichi Miyasaka. (2002). Fatigue characteristics of PZT capacitors with Ir/IrOx electrodes. 7–10.
19.
Takahashi, Kiyoshi, A. Sato, T. Takeuchi, et al.. (2001). Development and operation of superconducting NMR magnet beyond 900 MHz. IEEE Transactions on Applied Superconductivity. 11(1). 2347–2350. 28 indexed citations
20.
Shibutani, K., Tetsunari Hase, Seiji Hayashi, M. Shimada, & R. Ogawa. (1996). Fabrication of Bi-2212-Ag composite solenoid type superconducting magnet by partial melt process under high PO2. Physica B Condensed Matter. 216(3-4). 244–247. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Brauers Breakdown of academic impact, for papers by J Chu Breakdown of academic impact, for papers by Ioannis Stasinopoulos Breakdown of academic impact, for papers by Masashi Yamamoto Breakdown of academic impact, for papers by Christopher Bradley Breakdown of academic impact, for papers by Zhe Zheng Breakdown of academic impact, for papers by Satoru Ishida Breakdown of academic impact, for papers by Dali Zhang Breakdown of academic impact, for papers by Masao Yano Breakdown of academic impact, for papers by Gordon T. Kennedy
Rankless by CCL
2026